PDCD1 and neoplasm: Gene expression analysis in dMMR/MSI-H CRC demonstrated high levels of the immune checkpoints CTLA-4, PD-1, PD-L1, LAG-3, and IDO in different compartments, such as tumor-infiltrating lymphocytes, tumor stroma, and the invasive front of the tumor [26].